Screening of feature genes of the renal cell carcinoma with DNA microarray

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 22, 2013, Pages 2994-3001

  Feng, J Y ^a   Diao, X W ^a   Fan, M Q ^a   Wang, P X ^a   Xiao, Y ^a   Zhong, X ^a   Wu, R H ^a   Huang, Chi Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cluster analysis; Interaction network; Pathway analysis; Renal cell carcinoma

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 7; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DNA MICROARRAY; FABP7 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MOLECULAR BIOLOGY; OXIDATION REDUCTION REACTION; PROTEIN PROTEIN INTERACTION; UMOD GENE;

CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS;

EID: 84891752898     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. CAIRNS P. Renal Cell Carcinoma. Cancer Biomark 2011; 9: 461-473.
2. BARNHOLTZ-SLOAN JS, SEVERSON RK, VAISHAMPAYAN U, HUSSAIN M. Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States). Cancer Causes Control 2003; 14: 681-685.
3. GOTTARDO F, LIU CG, FERRACIN M, CALIN GA, FASSAN M, BASSI P, SEVIGNANI C, BYRNE D, NEGRINI M, PAGANO F, GOMELLA LG, CROCE CM, BAFFA R. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25: 387-392.
4. MOCH H, SCHRAML P, BUBENDORF L, MIRLACHER M, KONONEN J, GASSER T, MIHATSCH MJ, KALLIONIEMI OP, SAUTER G. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999; 154: 981-986.
5. LOWE LH, ISUANI BH, HELLER RM, STEIN SM, JOHNSON JE, NAVARRO OM, HERNANZ-SCHULMAN M. Pediatric renal masses: Wilms tumor and beyond. Radiographics 2000; 20: 1585-1603.
6. KNUUTILA S, AALTO Y, AUTIO K, BJORKQVIST AM, EL-RIFAI W, HEMMER S, HUHTA T, KETTUNEN E, KIURU-KUHLEFELT S, LARRAMENDY ML, LUSHNIKOVA T, MONNI O, PERE H, TAPPER J, TARKKANEN M, VARIS A, WASENIUS VM, WOLF M, ZHU Y. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-694.
7. ROYER-POKORA B. Genetics of pediatric renal tumors. Pediatr Nephrol 2013; 28: 13-23.
8. THOMASSON M, HEDMAN H, LJUNGBERG B, HENRIKSSON R. Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma. BMC Res Notes 2012; 5: 216.
9. MINNER S, RUMP D, TENNSTEDT P, SIMON R, BURANDT E, TERRACCIANO L, MOCH H, WILCZAK W, BOKEMEYER C, FISCH M, SAUTER G, EICHELBERG C. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer 2012; 118: 1268-1275.
10. MESTAS J, BURDICK MD, RECKAMP K, PANTUCK A, FIGLIN RA, STRIETER RM. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005; 175: 5351-5357.
11. PETRELLA BL, VINCENTI MP. Interleukin-1beta mediates metalloproteinase- dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein beta. Cancer Med 2012; 1: 17-27.
12. GLATZ JF, VAN NIEUWENHOVEN FA, LUIKEN JJ, SCHAAP FG, VAN DER VUSSE GJ. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1997; 57: 373-378.
13. TOLLE A, JUNG M, LEIN M, JOHANNSEN M, MILLER K, MOCH H, JUNG K, KRISTIANSEN G. Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer 2009; 9: 248.
14. MARKIC D, CELIC T, SPANJOL J, GRSKOVIC A, BOBINAC D, FUCKAR Z. Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer. Coll Antropol 2010; 34(Suppl 2): 149-153.
15. MARKIC D, CELIC T, GRSKOVIC A, SPANJOL J, FUCKAR Z, GRAHOVAC B, DORDEVIC G, BOBINAC D. mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma. Urol Int 2011; 87: 353-358.
16. LENBURG ME, LIOU LS, GERRY NP, FRAMPTON GM, COHEN HT, CHRISTMAN MF. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 2003; 3: 31.
17. SCHENA M, SHALON D, DAVIS RW, BROWN PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-470.
18. FUJITA A, SATO J, RODRIGUES L, FERREIRA C, SOGAYAR M. Evaluating different methods of microarray data normalization. BMC Bioinformatics 2006; 7: 469.
19. LI Q, BIRKBAK NJ, GYORFFY B, SZALLASI Z, EKLUND AC. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics 2011; 12: 474.
20. TROYANSKAYA O, CANTOR M, SHERLOCK G, BROWN P, HASTIE T, TIBSHIRANI R, BOTSTEIN D, ALTMAN RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525.
21. FUJITA A, SATO JR, RODRIGUES LDE O, FERREIRA CE, SOGAYAR MC. Evaluating different methods of microarray data normalization. BMC Bioinformatics 2006; 7: 469.
22. SMYTH GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer, New York 2005; 397-420.
23. BENJAMINI Y, AND HOCHBERG, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 1995; 57: 289-300.
24. EISEN MB, SPELLMAN PT, BROWN PO, BOTSTEIN D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863-14868.
25. NAM D, KIM SY. Gene-set approach for expression pattern analysis. Brief Bioinform 2008; 9: 189-197.
26. ALLISON DB, CUI X, PAGE GP, SABRIPOUR M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55-65.
27. HUANG DW SB, LEMPICKI RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 2009; 4: 44-57.
28. GIOT L, BADER JS, BROUWER C, CHAUDHURI A, KUANG B, LI Y, HAO YL, OOI CE, GODWIN B, VITOLS E, VIJAYADAMODAR G, POCHART P, MACHINENI H, WELSH M, KONG Y, ZERHUSEN B, MALCOLM R, VARRONE Z, COLLIS A, MINTO M, BURGESS S, MCDANIEL L, STIMPSON E, SPRIGGS F, WILLIAMS J, NEURATH K, IOIME N, AGEE M, VOSS E, FURTAK K, RENZULLI R, AANENSEN N, CARROLLA S, BICKELHAUPT E, LAZOVATSKY Y, DASILVA A, ZHONG J, STANYON CA, FINLEY RL, JR., WHITE KP, BRAVERMAN M, JARVIE T, GOLD S, LEACH M, KNIGHT J, SHIMKETS RA, MCKENNA MP, CHANT J, ROTHBERG JM. A protein interaction map of Drosophila melanogaster. Science 2003; 302: 1727-1736.
29. LI S, ARMSTRONG CM, BERTIN N, GE H, MILSTEIN S, BOXEM M, VIDALAIN PO, HAN JD, CHESNEAU A, HAO T, GOLDBERG DS, LI N, MARTINEZ M, RUAL JF, LAMESCH P, XU L, TEWARI M, WONG SL, ZHANG LV, BERRIZ GF, JACOTOT L, VAGLIO P, REBOUL J, HIROZANE-KISHIKAWA T, LI Q, GABEL HW, ELEWA A, BAUMGARTNER B, ROSE DJ, YU H, BOSAK S, SEQUERRA R, FRASER A, MANGO SE, SAXTON WM, STROME S, VAN DEN HEUVEL S, PIANO F, VANDENHAUTE J, SARDET C, GERSTEIN M, DOUCETTE-STAMM L, GUNSALUS KC, HARPER JW, CUSICK ME, ROTH FP, HILL DE, VIDAL M. A map of the interactome network of the metazoan C. elegans. Science 2004; 303: 540-543.
30. ZHANG QC, PETREY D, GARZON JI, DENG L, HONIG B. PrePPI: a structure-informed database of protein-protein interactions. Nucleic Acids Res 2013; 41: D828-833.
31. MONTOYA M. A PrePPI way to make predictions. Nat Struct Mol Biol 2012; 19: 1067-1067.
32. ZHANG B, KIROV S, SNODDY J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005; 33: W741-748.
33. DUNCAN DT, PRODDUTURI N, ZHANG. WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 2010; 11: P10.
34. WAGNER AJ, STUMBAUGH A, TIGUE Z, EDMONDSON J, PAQUET AC, FARMER DL, HAWGOOD S. Genetic analysis of congenital cystic adenomatoid malformation reveals a novel pulmonary gene: fatty acid binding protein-7 (brain type). Pediatr Res 2008; 64: 11-16.
35. TAKAOKA N, TAKAYAMA T, TERATANI T, SUGIYAMA T, MUGIYA S, OZONO S. Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines. BMC Mol Biol 2011; 12: 31.
36. DOMOTO T, MIYAMA Y, SUZUKI H, TERATANI T, ARAI K, SUGIYAMA T, TAKAYAMA T, MUGIYA S, OZONO S, NOZAWA R. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 2007; 98: 77-82.
37. DEGEORGES A, WANG F, FRIERSON HF, JR., SETH A, SIKES RA. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem 2000; 48: 747-754.
38. TAULAN M, PAQUET F, ARGILES A, DEMAILLE J, ROMEY MC. Comprehensive analysis of the renal transcriptional response to acute uranyl nitrate exposure. BMC Genomics 2006; 7: 2.
39. YOO KH, PARK YK, CHANG SG. DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma. Oncol Lett 2013; 5: 39-42.
40. TAMM I, HORSFALL FL, JR. Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 1950; 74: 106-108.
41. KOTTGEN A, YANG Q, SHIMMIN LC, TIN A, SCHAEFFER C, CORESH J, LIU X, RAMPOLDI L, HWANG SJ, BOERWINKLE E, HIXSON JE, KAO WH, FOX CS. Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing. PLoS One 2012; 7: e38311.
42. LIU Y, EL-ACHKAR TM, WU XR. Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap. J Biol Chem 2012; 287: 16365-16378.
43. WOZNIAK MB, LE CALVEZ-KELM F, ABEDI-ARDEKANI B, BYRNES G, DURAND G, CARREIRA C, MICHELON J, JANOUT V, HOLCATOVA I, FORETOVA L, BRISUDA A, LESUEUR F, MCKAY J, BRENNAN P, SCELO G. Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in czech republic and in the United States. PLoS One 2013; 8: e57886.
44. WANG L, PARK P, ZHANG H, LA MARCA F, CLAESON A, THAN K, RAHMAN S, LIN CY. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Int J Cancer 2012; 131: 1941-1950.